Table 2.
Association of miR-372 expression in human glioma tissues with different clinicopathological features
| Clinicopathological features | No. of cases |
miR-372 expression |
P | |
|---|---|---|---|---|
| High (n, %) | Low (n, %) | |||
|
WHO grade |
|
|
|
|
| I |
18 |
2 (11.1) |
16 (88.9) |
0.008 |
| II |
14 |
2 (14.3) |
12 (85.7) |
|
| III |
38 |
24 (63.2) |
14 (36.8) |
|
| IV |
58 |
50 (86.2) |
8 (13.8) |
|
|
Age |
|
|
|
|
| <55 |
52 |
33 (63.5) |
19 (36.5) |
NS |
| ≥55 |
76 |
45 (59.2) |
31 (40.8) |
|
|
Gender |
|
|
|
|
| Male |
76 |
45 (59.2) |
31 (40.8) |
NS |
| Female |
52 |
33 (63.5) |
19 (36.5) |
|
|
KPS |
|
|
|
|
| <80 |
78 |
56 (71.8) |
22 (28.2) |
0.01 |
| ≥80 | 50 | 22 (44.0) | 28 (56.0) | |